David Nassif

David Nassif

Chief Executive Officer at SIO GENE THERAPIES INC.

70 year
Health Technology
Consumer Services
Retail Trade

Profile

David W.
Nassif
currently works at Sio Gene Therapies, Inc., as CEO, CFO, Director, CAO & General Counsel from 2022 and Pharvaris NV, as Chief Financial Officer & Secretary from 2024.
Mr. Nassif also formerly worked at Cypros Pharmaceutical Corp., as Chief Financial Officer & Senior Vice President from 1993 to 1999, Zaldiva, Inc., as Chief Financial Officer, Zogenix, Inc., as CFO, Secretary, Treasurer & Executive VP in 2010, Amphastar Pharmaceuticals, Inc., as Chief Financial Officer & SVP-Global Licensing from 2002 to 2006, RealAge, Inc., as Chief Financial Officer & Senior Vice President from 2000 to 2001, Strategic Consulting Services, as Principal from 2001 to 2002, Strategic Consulting Services, as Principal in 2006, Histogen, Inc., as President & Chief Financial Officer from 2011 to 2014, SteadyMed Ltd., as Chief Financial Officer & Executive Vice President from 2015 to 2019, and Axovant Sciences, Inc., as Chief Financial Officer from 2019 to 2020.
Mr. Nassif received his undergraduate degree from the University of Virginia and graduate degree from the University of Virginia School of Law.

David Nassif active positions

CompaniesPositionStart
SIO GENE THERAPIES INC. Chief Executive Officer 30/01/2022
PHARVARIS N.V. Director of Finance/CFO 14/04/2024
All active positions of David Nassif

Former positions of David Nassif

CompaniesPositionEnd
Director of Finance/CFO 30/11/2020
STEADYMED LTD Director of Finance/CFO 29/06/2019
Director of Finance/CFO 31/08/2014
ZOGENIX, INC. Director of Finance/CFO 01/03/2010
Strategic Consulting Services Corporate Officer/Principal 30/09/2006
See the detail of David Nassif's experience

Training of David Nassif

University of Virginia Undergraduate Degree
University of Virginia School of Law Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Nassif's experience

Connections

77

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
AMPHASTAR PHARMACEUTICALS, INC.

Health Technology

PHARVARIS N.V.

Health Technology

Private companies9
Cypros Pharmaceutical Corp.

Health Technology

Retail Trade

Health Technology

Technology Services

Strategic Consulting Services

Health Services

Health Technology

Health Technology

Health Technology

See company connections